Qi Cha Cha·2025-11-19 01:56Core Viewpoint - The National Medical Products Administration of China released an opinion on November 17 to deepen cosmetic regulation reform and promote high-quality industry development through 24 reform measures focusing on innovation, registration management, risk prevention, smart regulation, and international alignment [1] Group 1: Regulatory Changes - The opinion includes measures to encourage innovation and optimize registration and filing management in the cosmetics industry [1] - It aims to strengthen risk prevention across the entire supply chain and enhance smart regulatory capabilities [1] - The initiative seeks to solidify the quality and safety baseline of cosmetics while fostering new productive forces [1] Group 2: Market Impact - Following the announcement, cosmetic stocks surged on November 18, with companies like Liren Lizhuang hitting the daily limit, and others such as Fulejia, Lafang Family, Bawi Co., and Shuiyang Co. also experiencing gains [1] - Current consumer sentiment is identified as a significant driver of cosmetic consumption [1] Group 3: Industry Statistics - As of November 18, there are 21.398 million existing cosmetic-related enterprises in China, with over 30% located in the East China region, followed by South China and Central China [6] - In 2025, 4.249 million cosmetic-related enterprises have been registered, with the highest number of new registrations in the Central China region, accounting for 27% [8]